rs141024159

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_144651.5(PXDNL):​c.2946C>T​(p.Ala982Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0129 in 1,600,496 control chromosomes in the GnomAD database, including 167 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 11 hom., cov: 33)
Exomes 𝑓: 0.013 ( 156 hom. )

Consequence

PXDNL
NM_144651.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.725

Publications

1 publications found
Variant links:
Genes affected
PXDNL (HGNC:26359): (peroxidasin like) Predicted to enable heme binding activity and peroxidase activity. Predicted to be involved in hydrogen peroxide catabolic process. Predicted to be located in cytoplasm. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.015).
BP6
Variant 8-51408678-G-A is Benign according to our data. Variant chr8-51408678-G-A is described in ClinVar as Benign. ClinVar VariationId is 403355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.725 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0115 (1747/152272) while in subpopulation NFE AF = 0.0161 (1095/68010). AF 95% confidence interval is 0.0153. There are 11 homozygotes in GnomAd4. There are 890 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PXDNLNM_144651.5 linkc.2946C>T p.Ala982Ala synonymous_variant Exon 17 of 23 ENST00000356297.5 NP_653252.4 A1KZ92-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PXDNLENST00000356297.5 linkc.2946C>T p.Ala982Ala synonymous_variant Exon 17 of 23 1 NM_144651.5 ENSP00000348645.4 A1KZ92-1
PXDNLENST00000522933.5 linkc.300C>T p.Ala100Ala synonymous_variant Exon 1 of 6 5 ENSP00000428114.1 H0YAV0
PXDNLENST00000522628.5 linkn.744C>T non_coding_transcript_exon_variant Exon 1 of 5 2 ENSP00000429855.1 K4DIA6

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1748
AN:
152154
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00203
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.00896
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00538
Gnomad FIN
AF:
0.0285
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0161
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0120
AC:
2645
AN:
221266
AF XY:
0.0120
show subpopulations
Gnomad AFR exome
AF:
0.00162
Gnomad AMR exome
AF:
0.00656
Gnomad ASJ exome
AF:
0.0163
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0293
Gnomad NFE exome
AF:
0.0149
Gnomad OTH exome
AF:
0.0133
GnomAD4 exome
AF:
0.0130
AC:
18866
AN:
1448224
Hom.:
156
Cov.:
31
AF XY:
0.0130
AC XY:
9340
AN XY:
719268
show subpopulations
African (AFR)
AF:
0.00165
AC:
55
AN:
33238
American (AMR)
AF:
0.00647
AC:
277
AN:
42812
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
394
AN:
25816
East Asian (EAS)
AF:
0.0000256
AC:
1
AN:
38996
South Asian (SAS)
AF:
0.00560
AC:
472
AN:
84286
European-Finnish (FIN)
AF:
0.0287
AC:
1496
AN:
52156
Middle Eastern (MID)
AF:
0.0146
AC:
84
AN:
5754
European-Non Finnish (NFE)
AF:
0.0139
AC:
15393
AN:
1105302
Other (OTH)
AF:
0.0116
AC:
694
AN:
59864
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1163
2326
3488
4651
5814
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0115
AC:
1747
AN:
152272
Hom.:
11
Cov.:
33
AF XY:
0.0120
AC XY:
890
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00202
AC:
84
AN:
41560
American (AMR)
AF:
0.00895
AC:
137
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00539
AC:
26
AN:
4826
European-Finnish (FIN)
AF:
0.0285
AC:
303
AN:
10614
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0161
AC:
1095
AN:
68010
Other (OTH)
AF:
0.0128
AC:
27
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
85
169
254
338
423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0136
Hom.:
4
Bravo
AF:
0.00935
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, silent variant -

PXDNL-related disorder Benign:1
Oct 14, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.80
DANN
Benign
0.51
PhyloP100
-0.72
PromoterAI
0.0054
Neutral
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141024159; hg19: chr8-52321238; API